The biggest regulatory shift in cannabis history is happening right now.
For the first time in nearly a century, the federal government might officially acknowledge that cannabis has medical value and is less dangerous than opiates.
The DEA is reviewing public comments and preparing for a final decision that could move cannabis from Schedule I to Schedule III. We should know the outcome in the next few weeks.
This is a big deal, because Cannabis rescheduling would trigger immediate, tangible changes for every cannabis business operator in America.
What Is Cannabis Rescheduling?
Currently, cannabis sits in Schedule I alongside heroin, LSD, and ecstasy. Schedule I substances are defined as having “no currently accepted medical use and a high potential for abuse.”
That classification never made sense. Thirty-eight states run medical cannabis programs, and 87% of Americans support medical cannabis according to recent Pew Research.
Cannabis rescheduling to Schedule III would classify it as having “moderate to low potential for dependence” with accepted medical applications. Schedule III includes drugs like Tylenol with codeine, ketamine, and anabolic steroids.
This change acknowledges what operators and patients have been shouting for years: Cannabis has legitimate medical value!
The 3 Major Cannabis Rescheduling Changes Coming for Your Business
1. 280E Tax Relief Could Save You Thousands
Here’s the big one: Cannabis rescheduling eliminates the IRS Section 280E tax penalty that’s been crushing operator profit margins.
Right now, cannabis businesses can’t deduct normal operating expenses like payroll, rent, marketing, or utilities. That’s because 280E only applies to businesses dealing in Schedule I and II substances.
But…if cannabis moves to Schedule III?
280E no longer applies.
Operators would finally be able to deduct standard business expenses like any other company. For most cannabis businesses, this represents tens of thousands in annual savings.
This tax relief also makes your business way more attractive to investors and frees up serious cash flow. Finally, this is the moment where cannabis operators stop just surviving, and start scaling (provided the DEA doesn’t hit snooze again).
2. Research Access Opens New Medicinal Opportunities
Schedule III drugs face significantly fewer research barriers than Schedule I substances.
More research means new medical applications and better legitimacy with doctors. The research pipeline has been blocked for decades, but cannabis rescheduling opens it up.
3. Banking and Financial Services Access
Banks have been reluctant to serve cannabis businesses in the past partly due to federal Schedule I classification. Moving to Schedule III makes cannabis businesses look less risky from a regulatory compliance perspective.
This could accelerate access to traditional banking services, business loans, and payment processing systems that operators need to scale efficiently.
Plus, reduced stigma at the federal level encourages more states to adopt medical or recreational programs. Cannabis rescheduling opens doors to broader market expansion.
What Cannabis Rescheduling Does NOT Do
Fake News: Rescheduling makes cannabis federally legal. Reality: Cannabis remains a controlled substance, not an approved drug. States still control their own cannabis laws.
Fake News: Cannabis rescheduling could allow shipping between states. Reality: You can’t mail cannabis from Colorado to California, even though both states allow it. It’ll still be federally illegal to transport cannabis across state lines. Schedule III wouldn’t change this. That will require separate federal action.
Your Next Steps as an Operator
The DEA’s final decision is expected within weeks. Regardless of the outcome, operators should prepare for change.
If cannabis rescheduling passes:
- Review your tax strategy with accountants familiar with standard business deductions
- Explore banking relationships that were previously unavailable
- Position your business for potential new market opportunities that could open up
If it doesn’t pass:
- REMAIN HOPEFUL AND OPTIMISTIC – we all know how fast this industry changes.
- Stay engaged in advocacy efforts for future rescheduling attempts
- Monitor state-level developments that continue regardless of federal action
Cannabis rescheduling would represent massive progress for the industry. But successful operators should prepare for multiple scenarios.
The Bottom Line on Cannabis Rescheduling
With 87% of Americans supporting medical cannabis and growing pressure from state programs, federal cannabis rescheduling feels inevitable. The question is timing.
This regulatory shift could save cannabis businesses thousands annually in tax relief while opening doors to banking, research, and reduced stigma.
But wise operators don’t wait for federal changes to optimize their businesses. They build compliant, profitable operations that succeed under current rules and scale when regulations improve.
Cannabis rescheduling would be transformative for the industry. Whether it happens in 2025 or takes longer, the momentum is building toward federal recognition of cannabis’s medical value and business legitimacy.
If you’re asking yourself “what’s next?”, we’re here for exactly that. We work directly with operators to stay compliant and build cannabis businesses that scale. As rescheduling plays out, we’ll keep you updated and help you be ready for the moment the doors open, you’re not just ready, you’re leading.
